Document is current

Article History

Received: 5 December 2025

Accepted: 28 February 2026

First Online: 17 March 2026

Declarations

:

: In accordance with the ethical principles stipulated in the “Ethical Review Measures for Human Life Sciences and Medical Research (2023)” issued by the National Health Commission, the “Good Clinical Practice for Medical Devices (2022)” issued by the National Medical Products Administration, the “Good Clinical Practice for Drug Clinical Trials (2020)” issued by the National Medical Products Administration, the “Helsinki Declaration” of the World Medical Association, and the “International Ethical Guidelines for Human Biomedical Research” of CIOMS, after approval by the Ethics Committee of the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, this research has been approved to be carried out in accordance with the approved documents. The approval number is: (2024) lunshen NO. (057) - YJS. The written informed consent was obtained from the patients prior to their involvement in the study.

: The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest. All the authors have read and approved the final manuscript.